Nitric oxide production by arsenite

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 533, Issue 1-2, 2003, Pages 173-182

  Gurr, Jia Ran ^a   Yih, Ling Huei ^b   Samikkannu, Thangavel ^b   Bau, Da Tian ^b   Lin, Shu Yu ^b   Jan, Kun Yan ^b  

^a HSING WU UNIVERSITY   (Taiwan)

^b INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

Author keywords

Arsenic; Arsenic inhibition of DNA repair; Arsenic induced apoptosis; Arsenic induced DNA damage; Reactive nitrogen species

Indexed keywords

ARSENIC TRIOXIDE; DNA; NITRIC OXIDE; PYRIMIDINE DIMER; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CARCINOMA; CELL STRAIN; CELL TYPE; CONCENTRATION RESPONSE; DNA DAMAGE; DNA REPAIR; DNA STRAND; ENDOTHELIUM LESION; EXPOSURE; HUMAN; INFLAMMATION; MICRONUCLEUS; MOLECULAR DYNAMICS; OXIDATION; PATHOLOGY; PRIORITY JOURNAL; REVIEW; ULTRAVIOLET RADIATION; UPREGULATION;

EID: 0344845150     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2003.08.024     Document Type: Review

References (118)

1. Tseng W.P. Blackfoot disease in Taiwan: a 30-year follow-up study. Angiology. 40:1989;547-558.
2. Lai M.S., Hsueh Y.M., Chen C.J., Shyu M.P., Chen S.Y., Kuo T.L., Wu M.M., Tai T.Y. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am. J. Epidemiol. 139:1994;484-492.
3. Chen C.J., Hsueh Y.M., Lai M.S., Shyu M.P., Chen S.Y., Wu M.M., Kuo T.L., Tai T.Y. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension. 25:1995;53-60.
4. Chen C.J. Blackfoot disease. Lancet. 336:1990;442.
5. Chen C.J., Chen C.W., Wu M.M., Kuo T.L. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer. 66:1992;888-892.
6. Yamanaka K., Hasegawa A., Sawamura R., Okada S. Cellular response to oxidative damage in lung induced by the administration of dimethylarsinic acid, a major metabolite of inorganic arsenics, in mice. Toxicol. Appl. Pharmacol. 108:1991;205-213.
7. Lee T.C., Ho I.C. Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblasts. Arch. Toxicol. 69:1995;498-504.
8. Wang T.S., Kuo C.F., Jan K.Y., Huang H. Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J. Cell Physiol. 169:1996;256-268.
9. Barchowsky A., Klei L.R., Dudek E.J., Swartz H.M., James P.E. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic. Biol. Med. 27:1999;1405-1412.
10. Liu S.X., Athar M., Lippai I., Waldren C., Hei T.K. Induction of oxyradicals by arsenic: implication for mechanism of genotoxicity. Proc. Natl. Acad. Sci. U.S.A. 98:2001;1643-1648.
11. Wang T.S., Hsu T.Y., Chung C.H., Wang A.S., Bau D.T., Jan K.Y. Arsenite induces oxidative DNA adducts and DNA-protein cross-links in mammalian cells. Free Radic. Biol. Med. 31:2001;321-330.
12. Samikkannu T., Yih L.H., Wang A.S.S., Lin S.Y., Chen T.C., Jan K.Y. Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity. Chem. Res. Toxicol. 16:2003;409-414.
13. Lala P.K., Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2:2001;149-156.
14. Hanafy K.A., Krumenacker J.S., Murad F. NO, nitrotyrosine, and cyclic GMP in signal transduction. Med. Sci. Monit. 7:2001;801-819.
15. Stamler J.S., Lamas S., Fang F.C. Nitrosylation, the prototypic redox-based signaling mechanism. Cell. 106:2001;675-683.
16. Moncada S., Erusalimsky J.D. Does nitric oxide modulate mitochondrial energy generation and apoptosis? Nat. Rev. Mol. Cell. Biol. 3:2002;214-220.
17. Huang P.L. Lessons learned from nitric oxide synthase knockout animals. Semin. Perinatol. 24:2000;87-90.
18. Dawson V.L., Dawson T.M. Nitric oxide in neurodegeneration. Prog. Brain Res. 118:1998;215-229.
19. Nandagopal K., Dawson T.M., Dawson V.L. Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance. J. Pharmacol. Exp. Ther. 297:2001;474-478.
20. Dawn B., Bolli R. Role of nitric oxide in myocardial preconditioning. Ann. N. Y. Acad. Sci. 962:2002;18-41.
21. Heneka M.T., Landreth G.E., Feinstein D.L. Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease. Ann. Neurol. 49:2001;276.
22. Esaki T., Hayashi T., Muto E., Kano H., Kumar T.N., Asai Y., Sumi D., Iguchi A. Expression of inducible nitric oxide synthase and Fas/Fas ligand correlates with the incidence of apoptotic cell death in atheromatous plaques of human coronary arteries. Nitric Oxide. 4:2000;561-571.
23. Murray I.A., Daniels I., Coupland K., Smith J.A., Long R.G. Increased activity and expression of iNOS in human duodenal enterocytes from patients with celiac disease. Am. J. Physiol. Gastrointest Liver Physiol. 283:2002;G319-G326.
24. Liu J.S., Zhao M.L., Brosnan C.F., Lee S.C. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am. J. Pathol. 158:2001;2057-2066.
25. Borderie D., Hilliquin P., Hernvann A., Kahan A., Menkes C.J., Ekindjian O.G. Nitric oxide synthase is expressed in the lymphomononuclear cells of synovial fluid in patients with rheumatoid arthritis. J. Rheumatol. 26:1999;2083-2088.
26. Knott C., Stern G., Wilkin G.P. Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol. Cell. Neurosci. 16:2000;724-739.
27. Forster C., Clark H.B., Ross M.E., Iadecola C. Inducible nitric oxide synthase expression in human cerebral infarcts. Acta Neuropathol. (Berlin). 97:1999;215-220.
28. Xu W., Liu L.Z., Loizidou M., Ahmed M., Charles I.G. The role of nitric oxide in cancer. Cell Res. 12:2002;311-320.
29. Vallance P., Leiper J. Blocking NO synthesis: how, where and why? Nat. Rev. Drug Discov. 1:2002;939-950.
30. Tamir S., Tannenbaum S.R. The role of nitric oxide (NO·) in the carcinogenic process. Biochim. Biophys. Acta. 1288:1996;F31-F36.
31. Rogers P.A., Eide L., Klungland A., Ding H. Reversible inactivation of E. coli endonuclease III via modification of its [4Fe-4S] cluster by nitric oxide. DNA Repair (Amsterdam). 2:2003;809-817.
32. 6-alkylguanine-DNA alkyltransferase after reaction with nitric oxide. Cancer Res. 62:2002;3037-3043.
33. Jaiswal M., LaRusso N.F., Gores G.J. Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am. J. Physiol. Gastrointest. Liver Physiol. 281:2001;G626-G634.
34. Wink D.A., Laval J. The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo. Carcinogenesis. 15:1994;2125-2129.
35. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87:1990;1620-1624.
36. Pryor W.A., Squadrito G.L. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268:1995;L699-L722.
37. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266:1991;4244-4250.
38. Beckman J.S. The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J. Dev. Physiol. 15:1991;53-59.
39. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J.C., Smith C.D., Beckman J.S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298:1992;431-437.
40. MacMillan-Crow L.A., Crow J.P., Kerby J.D., Beckman J.S., Thompson J.A. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc. Natl. Acad. Sci. U.S.A. 93:1996;11853-11858.
41. Yamakura F., Taka H., Fujimura T., Murayama K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34- to 3-nitrotyrosine. J. Biol. Chem. 273:1998;14085-14089.
42. MacMillan-Crow L.A., Crow J.P., Thompson J.A. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry. 37:1998;1613-1622.
43. Henry Y., Ducrocq C., Drapier J.C., Servent D., Pellat C., Guissani A. Nitric oxide, a biological effector. Electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whole cells. Eur. Biophys. J. 20:1991;1-15.
44. Ignarro L.J., Fukuto J.M., Griscavage J.M., Rogers N.E., Byrns R.E. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc. Natl. Acad. Sci. U.S.A. 90:1993;8103-8107.
45. Misko T.P., Schilling R.J., Salvemini D., Moore W.M., Currie M.G. A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem. 214:1993;11-16.
46. Lynn S., Lai H.T., Gurr J.R., Jan K.Y. Arsenite retards DNA break rejoining by inhibiting DNA ligation. Mutagenesis. 12:1997;353-358.
47. Gurr J.R., Liu F., Lynn S., Jan K.Y. Calcium-dependent nitric oxide production is involved in arsenite-induced micronuclei. Mutat. Res. 416:1998;137-148.
48. Mordan L.J., Burnett T.S., Zhang L.X., Tom J., Cooney R.V. Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts. Carcinogenesis. 14:1993;1555-1559.
49. Chattopadhyay S., Bhaumik S., Nag Chaudhury A., Das Gupta S. Arsenic induced changes in growth development and apoptosis in neonatal and adult brain cells in vivo and in tissue culture. Toxicol. Lett. 128:2002;73-84.
50. Liu F., Jan K.Y. DNA damage in arsenite- and cadmium-treated bovine aortic endothelial cells. Free Radic. Biol. Med. 28:2000;55-63.
51. Bunderson M., Coffin J.D., Beall H.D. Arsenic induces peroxynitrite generation and cyclooxygenase-2 protein expression in aortic endothelial cells: possible role in atherosclerosis. Toxicol. Appl. Pharmacol. 184:2002;11-18.
52. Kao Y.H., Yu C.L., Chang L.W., Yu H.S. Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro. Chem. Res. Toxicol. 16:2003;460-468.
53. Souza K., Maddock D.A., Zhang Q., Chen J., Chiu C., Mehta S., Wan Y. Arsenite activation of P13K/AKT cell survival pathway is mediated by p38 in cultured human keratinocytes. Mol. Med. 7:2001;767-772.
54. Waalkes M.P., Keefer L.K., Diwan B.A. Induction of proliferative lesions of the uterus, testes, and liver in swiss mice given repeated injections of sodium arsenate: possible estrogenic mode of action. Toxicol. Appl. Pharmacol. 166:2000;24-35.
55. Christodoulides N., Durante W., Kroll M.H., Schafer A.I. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation. 91:1995;2306-2309.
56. de Vera M.E., Kim Y.M., Wong H.R., Wang Q., Billiar T.R., Geller D.A. Heat shock response inhibits cytokine-inducible nitric oxide synthase expression in rat hepatocytes. Hepatology. 24:1996;1238-1245.
57. de Vera M.E., Wong J.M., Zhou J.Y., Tzeng E., Wong H.R., Billiar T.R., Geller D.A. Cytokine-induced nitric oxide synthase gene transcription is blocked by the heat shock response in human liver cells. Surgery. 120:1996;144-149.
58. Wong H.R., Finder J.D., Wasserloos K., Pitt B.R. Expression of iNOS in cultured rat pulmonary artery smooth muscle cells is inhibited by the heat shock response. Am. J. Physiol. 269:1995;L843-L848.
59. Chakravortty D., Kato Y., Sugiyama T., Koide N., Mu M.M., Yoshida T., Yokochi T. The inhibitory action of sodium arsenite on lipopolysaccharide- induced nitric oxide production in RAW 267.4 macrophage cells: a role of Raf-1 in lipopolysaccharide signaling. J. Immunol. 166:2001;2011-2017.
60. Hauser G.J., Wasserloos K., Dayao E.K., Pitt B.R. Effect of sodium arsenite on iNOS expression and vascular hyporeactivity associated with cecal ligation and puncture in the rat. Shock. 15:2001;73-76.
61. Cooney R.V.a.H., Harwood P.J. Effects of arsenic compounds on proliferation and nitric oxide synthesis in C3H 10T1/2 murine fibroblasts. Appl. Organometal Chem. 11:1997;397-402.
62. Lee M.Y., Jung B.I., Chung S.M., Bae O.N., Lee J.Y., Park J.D., Yang J.S., Lee H., Chung J.H. Arsenic-induced dysfunction in relaxation of blood vessels. Environ. Health Perspect. 111:2003;513-517.
63. Yuan S.S., Hou M.F., Chang H.L., Chan T.F., Wu Y.H., Wu Y.C., Su J.H. Arsenite-induced nitric oxide generation is cell cycle-dependent and aberrant in NBS cells. Toxicol. In Vitro. 17:2003;139-143.
64. Pi J., Kumagai Y., Sun G., Yamauchi H., Yoshida T., Iso H., Endo A., Yu L., Yuki K., Miyauchi T., Shimojo N. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in inner Mongolia. Free Radic. Biol. Med. 28:2000;1137-1142.
65. Pi J., Horiguchi S., Sun Y., Nikaido M., Shimojo N., Hayashi T., Yamauchi H., Itoh K., Yamamoto M., Sun G., Waalkes M.P., Kumagai Y. A potential mechanism for the impairment of nitric oxide formation caused by prolonged oral exposure to arsenate in rabbits. Free Radic. Biol. Med. 35:2003;102-113.
66. Leaf C.D., Wishnok J.S., Tannenbaum S.R. Endogenous incorporation of nitric oxide from L-arginine into N-nitrosomorpholine stimulated by Escherichia coli lipopolysaccharide in the rat. Carcinogenesis. 12:1991;537-539.
67. Tsuda M., Kurashima Y. Tobacco smoking, chewing, and snuff dipping: factors contributing to the endogenous formation of N-nitroso compounds. Crit. Rev. Toxicol. 21:1991;243-253.
68. Wink D.A., Kasprzak K.S., Maragos C.M., Elespuru R.K., Misra M., Dunams T.M., Cebula T.A., Koch W.H., Andrews A.W., Allen J.S., Larry K.K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science. 254:1991;1001-1003.
69. Bau D.T., Wang T.S., Chung C.H., Wang A.S., Jan K.Y. Oxidative DNA adducts and DNA-protein cross-links are the major DNA lesions induced by arsenite. Environ. Health Perspect. 110(Suppl. 5):2002;753-756.
70. Lynn S., Gurr J.R., Lai H.T., Jan K.Y. NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ. Res. 86:2000;514-519.
71. Wang T.S., Chung C.H., Wang A.S., Bau D.T., Samikkannu T., Jan K.Y., Cheng Y.M., Lee T.C. Endonuclease III, formamidopyrimidine-DNA glycosylase, and proteinase K additively enhance arsenic-induced DNA strand breaks in human cells. Chem. Res. Toxicol. 15:2002;1254-1258.
72. Lindahl T., Satoh M.S., Poirier G.G., Klungland A. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem. Sci. 20:1995;405-411.
73. Seeberg E., Eide L., Bjoras M. The base excision repair pathway. Trends Biochem. Sci. 20:1995;391-397.
74. Zhang J., Snyder S.H. Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. U.S.A. 89:1992;9382-9385.
75. + depletion. Biochem. Biophys. Res. Commun. 199:1994;1270-1277.
76. Heller B., Wang Z.Q., Wagner E.F., Radons J., Burkle A., Fehsel K., Burkart V., Kolb H. Inactivation of the poly(ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J. Biol. Chem. 270:1995;11176-11180.
77. Lee T.C., Wang-Wuu S., Huang R.Y., Lee K.C., Jan K.Y. Differential effects of pre- and posttreatment of sodium arsenite on the genotoxicity of methyl methanesulfonate in Chinese hamster ovary cells. Cancer Res. 46:1986;1854-1857.
78. Li J.H., Rossman T.G. Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol. Toxicol. 2:1989;1-9.
79. Lee-Chen S.F., Gurr J.R., Lin I.B., Jan K.Y. Arsenite enhances DNA double-strand breaks and cell killing of methyl methanesulfonate-treated cells by inhibiting the excision of alkali-labile sites. Mutat. Res. 294:1993;21-28.
80. Schreiber V., Ame J.C., Dolle P., Schultz I., Rinaldi B., Fraulob V., Menissier-de Murcia J., de Murcia G. Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J. Biol. Chem. 277:2002;23028-23036.
81. Yager J.W., Wiencke J.K. Inhibition of poly(ADP-ribose) polymerase by arsenite. Mutat. Res. 386:1997;345-351.
82. Hartwig A., Pelzer A., Asmuss M., Burkle A. Very low concentrations of arsenite suppress poly(ADP-ribosyl)ation in mammalian cells. Int. J. Cancer. 104:2003;1-6.
83. 6-methylguanine-DNA-methyltransferase. Carcinogenesis. 15:1994;443-447.
84. Jaiswal M., LaRusso N.F., Burgart L.J., Gores G.J. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res. 60:2000;184-190.
85. Lee T.C., Huang R.Y., Jan K.Y. Sodium arsenite enhances the cytotoxicity, clastogenicity, and 6-thioguanine-resistant mutagenicity of ultraviolet light in Chinese hamster ovary cells. Mutat. Res. 148:1985;83-89.
86. Okui T., Fujiwara Y. Inhibition of human excision DNA repair by inorganic arsenic and the co-mutagenic effect in V79 Chinese hamster cells. Mutat. Res. 172:1986;69-76.
87. Huang H., Huang C.F., Huang J.S., Wang T.C., Jan K.Y. The transition from late G1 to early S phase is most vulnerable to the coclastogenic effect of ultraviolet radiation plus arsenite. Int. J. Radiat. Biol. 61:1992;57-62.
88. Lee-Chen S.F., Yu C.T., Jan K.Y. Effect of arsenite on the DNA repair of UV-irradiated Chinese hamster ovary cells. Mutagenesis. 7:1992;51-55.
89. Wang T.C., Huang J.S., Yang V.C., Lan H.J., Lin C.J., Jan K.Y. Delay of the excision of UV light-induced DNA adducts is involved in the coclastogenicity of UV light plus arsenite. Int. J. Radiat. Biol. 66:1994;367-372.
90. Hartwig A., Groblinghoff U.D., Beyersmann D., Natarajan A.T., Filon R., Mullenders L.H. Interaction of arsenic(III) with nucleotide excision repair in UV-irradiated human fibroblasts. Carcinogenesis. 18:1997;399-405.
91. Bau D.T., Gurr J.R., Jan K.Y. Nitric oxide is involved in arsenite inhibition of pyrimidine dimer excision. Carcinogenesis. 22:2001;709-716.
92. Wang T.S., Shu Y.F., Liu Y.C., Jan K.Y., Huang H. Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicology. 121:1997;229-237.
93. 3) in the treatment of acute promyelocytic leukemia (APL). II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood. 89:1997;3354-3360.
94. Soignet S.L. Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia. Oncologist. 6(Suppl. 2):2001;11-16.
95. Zhao W.L., Chen S.J., Shen Y., Xu L., Cai X., Chen G.Q., Shen Z.X., Chen Z., Wang Z.Y. Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical and basic studies. Leuk. Lymphoma. 42:2001;1265-1273.
96. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood. 88:1996;1052-1061.
97. Gurr J.R., Bau D.T., Liu F., Lynn S., Jan K.Y. Dithiothreitol enhances arsenic trioxide-induced apoptosis in NB4 cells. Mol. Pharmacol. 56:1999;102-109.
98. Shen Z.Y., Shen W.Y., Chen M.H., Shen J., Cai W.J., Yi Z. Nitric oxide and calcium ions in apoptotic esophageal carcinoma cells induced by arsenite. World J. Gastroenterol. 8:2002;40-43.
99. Forrester K., Ambs S., Lupold S.E., Kapust R.B., Spillare E.A., Weinberg W.C., Felley-Bosco E., Wang X.W., Geller D.A., Tzeng E., Billiar T.R., Harris C.C. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. Proc. Natl. Acad. Sci. U.S.A. 93:1996;2442-2447.
100. Ambs S., Hussain S.P., Harris C.C. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J. 11:1997;443-448.
101. Fiscus R.R., Yuen J.P., Chan S.L., Kwong J.H., Chew S.B. Nitric oxide and cyclic GMP as pro- and anti-apoptotic agents. J. Card. Surg. 17:2002;336-339.
102. Chen C.J., Wu M.M., Lee S.S., Wang J.D., Cheng S.H., Wu H.Y. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis. 8:1988;452-460.
103. Chen S.L., Yeh S.J., Yang M.H., Lin T.H. Trace element concentration and arsenic speciation in the well water of a Taiwan area with endemic blackfoot disease. Biol. Trace Elem. Res. 48:1995;263-274.
104. Rees D.D., Palmer R.M., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A. 86:1989;3375-3378.
105. Nava E., Luscher T.F. Endothelium-derived vasoactive factors in hypertension: nitric oxide and endothelin. J. Hypertension Suppl. 13:1995;S39-S48.
106. Moncada S. Nitric oxide gas: mediator, modulator, and pathophysiologic entity. J. Lab. Clin. Med. 120:1992;187-191.
107. Harrison D.G. Endothelial dysfunction in atherosclerosis. Basic Res. Cardiol. 89(Suppl. 1):1994;87-102.
108. Kroncke K.D., Fehsel K., Kolb-Bachofen V. Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol. 113:1998;147-156.
109. Suschek C.V., Krischel V., Bruch-Gerharz D., Berendji D., Krutmann J., Kroncke K.D., Kolb-Bachofen V. Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 up-regulation. J. Biol. Chem. 274:1999;6130-6137.
110. Mirvish S.S. Experimental evidence for inhibition of N-nitroso compound formation as a factor in the negative correlation between Vitamin C consumption and the incidence of certain cancers. Cancer Res. 54:1994;1948s-1951s.
111. Ohshima H., Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305:1994;253-264.
112. Thomsen L.L., Miles D.W., Happerfield L., Bobrow L.G., Knowles R.G., Moncada S. Nitric oxide synthase activity in human breast cancer. Br. J. Cancer. 72:1995;41-44.
113. Kroes R., van Logten M.J., Berkvens J.M., de Vries T., van Esch G.J. Study on the carcinogenicity of lead arsenate and sodium arsenate and on the possible synergistic effect of diethylnitrosamine. Food Cosmet. Toxicol. 12:1974;671-679.
114. Thorgeirsson U.P., Dalgard D.W., Reeves J., Adamson R.H. Tumor incidence in a chemical carcinogenesis study of nonhuman primates. Regulat. Toxicol. Pharmacol. 19:1994;130-151.
115. Byron W.R., Bierbower G.W., Brouwer J.B., Hansen W.H. Pathologic changes in rats and dogs from two-year feeding of sodium arsenite or sodium arsenate. Toxicol. Appl. Pharmacol. 10:1967;132-147.
116. Wiencke J.K., Yager J.W., Varkonyi A., Hultner M., Lutze L.H. Study of arsenic mutagenesis using the plasmid shuttle vector pZ189 propagated in DNA repair proficient human cells. Mutat. Res. 386:1997;335-344.
117. Hei T.K., Liu S.X., Waldren C. Mutagenicity of arsenic in mammalian cells: role of reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8103-8107.
118. Mass M.J., Tennant A., Roop B.C., Cullen W.R., Styblo M., Thomas D.J., Kligerman A.D. Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 14:2001;355-361.